EX-99.1 2 dex991.htm PRESS RELEASE Press Release

Exhibit 99.1

 

LEVI

STRAUSS

    & CO.

 NEWS

        1155 Battery Street, San Francisco, CA 94111
     Investor Contact:    Allison Malkin
          Integrated Corporate Relations, Inc.
          (203) 682-8200
     Media Contact:    Jeff Beckman
          Levi Strauss & Co.
          (415) 501-3317

 

LEVI STRAUSS & CO. ANNOUNCES THIRD-QUARTER 2004 FINANCIAL RESULTS

 

SAN FRANCISCO (October 12, 2004) – Levi Strauss & Co. (LS&CO.) today announced financial results for the third quarter ended August 29, 2004 and filed its third-quarter 2004 Form 10-Q with the Securities and Exchange Commission. Results for the quarter, compared to the same quarter in the prior year, reflected continued improvements in gross profit; selling, general and administrative (SG&A) expense; and net income on expected lower net sales.

 

Third-quarter 2004 net sales were $995 million compared to $1,084 million for the third quarter of 2003, representing a decrease of $89 million or 8.2 percent on a reported basis and 10.2 percent on a constant-currency basis. The expected sales decrease was due primarily to the impact of approximately $65 million in initial product shipments in the third quarter of 2003 to fill retail shelves at 3,000 U.S. Wal-Mart stores for the launch of the Levi Strauss Signature brand. In addition, actions the company has taken this year that helped improve its profitability contributed to the overall sales decrease during the quarter, including:

 

  licensing or exiting unprofitable and underperforming businesses in order to focus on more profitable core-product assortments, resulting in approximately $24 million in reduced sales; and

 

  a planned reduction in closeout sales to off-price retail channels in 2004, decreasing sales by approximately $19 million.

 

The sales declines were partially offset by the continued growth of the company’s Asia Pacific business, which generated an 11.5 percent net sales increase on a constant currency basis.

 

“We’re doing what we said we’d do,” said Phil Marineau, chief executive officer. “We set out to improve our profitability this year and that’s what we’ve done so far. Our business is healthier and more competitive today than when we began the year. In addition to strengthening the financial performance of the company, we are increasing consumer demand for our products through new marketing and product innovation.”


Third-Quarter 2004 Results

 

  Gross profit was $456 million, or 45.9 percent of net sales, compared to $397 million, or 36.7 percent of net sales in the third quarter of 2003. Gross profit in the 2004 period benefited from improved management of returns, allowances and product transition costs; increased sales of premium-priced products in Europe and Asia; lower product sourcing costs; and stronger foreign currencies. Year-to-date gross margin was 43.8 percent of net sales. The gross margin improvement during the third quarter resulted from the unusually favorable mix of more profitable core products, as well as the company’s product rationalization efforts.

 

  Selling, general and administrative expense decreased to $301 million from $343 million in the third quarter of 2003. Lower SG&A expense was attributable primarily to a $14 million reduction in advertising expense, an approximately $9 million decrease in post-retirement healthcare expense and an approximately $19 million reduction in other SG&A expenses. The company is reporting long-term incentive compensation expense separately from SG&A expense in both the current and prior year period because of the substantial impact of a $129.1 million net reversal of long-term incentive compensation expense in the 2003 period.

 

  Advertising expense decreased 19.6 percent to $57 million, or 5.7 percent of net sales, compared to $70 million, or 6.5 percent of net sales in the 2003 period.

 

  Post-retirement healthcare expense was a net benefit of approximately $7.4 million compared to a $1.5 million expense in the prior year period. The improvement reflects the impact of our headcount reductions and previously reported post-retirement medical plan changes for certain employees and retired participants.

 

  Lower other SG&A reflects the cost reductions related to reorganization initiatives, partially offset by higher annual incentive expense and a foreign currency translation increase.

 

  Long-term incentive compensation expense for the quarter was $10.7 million compared to a $129.1 million net reversal in the 2003 period. The reversal was made in the prior year as a result of lower than expected incentive payouts due to the decline in the company’s performance during the second half of 2003.

 

  Restructuring charges, net of reversals, were $28.1 million in the third quarter of 2004 versus restructuring charges, net of reversals, of $2.6 million in the 2003 period. The third-quarter 2004 charges were primarily associated with the closure of manufacturing plants in Spain and Australia as well as headcount reductions in the United States and Europe as the company continued to streamline operations.


  Operating income for the quarter decreased 33 percent to $128.6 million, or 12.9 percent of revenue, compared to $191 million, or 17.6 percent of revenue, for the same period of 2003. Operating income was primarily impacted by the reversal of long-term incentive compensation accruals during the third quarter of 2003 described above and increased restructuring charges during the same period in 2004, partially offset by increased gross profit and lower SG&A.

 

  Income tax expense for the quarter was $17.8 million, compared to $135.5 million in the 2003 period. The third-quarter 2003 tax expense included a provision of approximately $223 million related to an additional valuation allowance against deferred tax assets.

 

  Net income for the third quarter of 2004 increased to $46.6 million compared to a net loss of $4.3 million for the third quarter of 2003. The improvement was due primarily to higher gross profit, lower SG&A expense and lower tax expense, partially offset by the impact of the reversal of long-term incentive compensation accruals in 2003 and increased restructuring charges this year.

 

As of August 29, 2004, total debt, less cash, stood at $2.0 billion compared to $2.1 billion at the end of fiscal year 2003. As of October 10, 2004, the company had total available liquidity of approximately $562.2 million, consisting of approximately $317.0 million in liquid short-term investments and approximately $245.2 million in net available borrowing capacity under its revolving credit facility.

 

“Our results – improved gross profit, lower SG&A, improved cash flow and a stronger balance sheet – were consistent with our strategy to focus our brands and drive a more profitable business. Accordingly, we have rationalized our sales base and taken a rigorous look at reducing expenses by business and function across the entire company,” said Jim Fogarty, chief financial officer. “For example, during the third quarter we continued to streamline our U.S. and European organizations, announced our intent to close our Australian manufacturing plant at the end of November and reached an agreement with employee and union representatives on the terms of the closure of our two Spanish factories.”

 

Investor Conference Call

 

The company’s third-quarter investor conference call will be available through a live audio Webcast at http://levistrauss.com/news/webcast.htm today, October 12, 2004, at 7 a.m. PDT/10 a.m. EDT. A replay is available on the Web site the same day and will be archived for six months. A telephone replay also is available at 800-642-1687 in the United States and Canada, or 706-645-9291 internationally; I.D. #1050518 through November 12, 2004.

 

This news release contains, in addition to historical information, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We have based these forward-looking statements on our current assumptions, expectations and projections about future events. We use words like “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions to identify forward-looking statements, although not all forward-looking statements contain these words. These forward-looking statements are necessarily estimates reflecting the best judgment of our senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. Investors should consider the information contained in our filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the fiscal year ended 2003, especially in the Management’s Discussion and Analysis - “Financial Condition and Results of Operations” and “Factors That May Affect Future Results” sections, our most recent Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. Other unknown or unpredictable factors also could have material adverse effects on our future results, performance or achievements. In light of these risks, uncertainties, assumptions and factors, the forward-looking events discussed in this news release may not occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date stated, or if no date is stated, as of the date of this news release. We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this news release to reflect circumstances existing after the date of this news release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.

 

###


LEVI STRAUSS & CO. AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

 

    

August 29,

2004


   

November 30,

2003


 
ASSETS                 

Current Assets:

                

Cash and cash equivalents

   $ 286,194     $ 203,940  

Restricted cash

     2,053       —    

Trade receivables, net of bad debt allowance of $21,102 in 2004 and $26,956 in 2003

     563,112       555,106  

Inventories

     539,126       680,068  

Deferred tax assets, net of valuation allowance of $25,281 in both 2004 and 2003

     131,827       131,827  

Other current assets

     92,102       104,176  
    


 


Total current assets

     1,614,414       1,675,117  

Property, plant and equipment, net of accumulated depreciation of $473,085 in 2004 and $491,121 in 2003

     419,987       486,714  

Goodwill, net of accumulated amortization of $151,569 in 2004 and in 2003

     199,905       199,905  

Other intangible assets, net of accumulated amortization of $35,022 in 2004 and $36,349 in 2003

     44,645       44,722  

Non-current deferred tax assets, net of valuation allowance of $324,269 in both 2004 and 2003

     490,021       490,021  

Other assets

     77,028       87,283  
    


 


Total Assets

   $ 2,846,000     $ 2,983,762  
    


 


LIABILITIES AND STOCKHOLDERS’ DEFICIT                 

Current Liabilities:

                

Current maturities of long-term debt and short-term borrowings

   $ 81,615     $ 34,700  

Current maturities of capital lease

     1,367       —    

Accounts payable

     224,329       296,188  

Restructuring reserves

     67,530       96,406  

Accrued liabilities

     204,527       244,520  

Accrued salaries, wages and employee benefits

     261,413       195,129  

Accrued taxes

     118,010       29,863  
    


 


Total current liabilities

     958,791       896,806  

Long-term debt, less current maturities

     2,222,947       2,281,729  

Long-term capital lease, less current maturities

     5,295       —    

Postretirement medical benefits

     498,713       555,008  

Pension liability

     231,313       250,814  

Long-term employee related benefits

     158,328       193,188  

Long-term tax liabilities

     40,377       143,082  

Other long-term liabilities

     33,667       32,576  

Minority interest

     24,126       23,731  
    


 


Total liabilities

     4,173,557       4,376,934  
    


 


Stockholders’ Deficit:

                

Common stock—$.01 par value; 270,000,000 shares authorized; 37,278,238 shares issued and outstanding

     373       373  

Additional paid-in capital

     88,808       88,808  

Accumulated deficit

     (1,334,997 )     (1,384,818 )

Accumulated other comprehensive loss

     (81,741 )     (97,535 )
    


 


Total stockholders’ deficit

     (1,327,557 )     (1,393,172 )
    


 


Total Liabilities and Stockholders’ Deficit

   $ 2,846,000     $ 2,983,762  
    


 


 

The notes accompanying our financial statements in our Form 10Q are an integral part of these financial statements.


LEVI STRAUSS & CO. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Dollars in Thousands)

(Unaudited)

 

     Three Months Ended
August 29, 2004


    Three Months Ended
August 24, 2003


   

Nine Months Ended

August 29, 2004


    Nine Months Ended
August 24, 2003


 

Net sales

   $ 994,626     $ 1,083,748     $ 2,915,763     $ 2,892,803  

Cost of goods sold

     538,179       686,487       1,638,377       1,742,194  
    


 


 


 


Gross profit

     456,447       397,261       1,277,386       1,150,609  

Selling, general and administrative expenses

     300,540       343,472       894,965       1,003,767  

Long-term incentive compensation plan expense (reversal)

     10,735       (129,127 )     37,066       (139,262 )

Other operating income

     (11,593 )     (10,280 )     (29,626 )     (27,348 )

Restructuring charges, net of reversals

     28,117       2,610       108,158       (5,776 )
    


 


 


 


Operating income

     128,648       190,586       266,823       319,228  

Interest expense

     64,252       62,524       197,687       185,549  

Other expense (income), net

     10       (3,125 )     2,458       51,673  
    


 


 


 


Income before taxes

     64,386       131,187       66,678       82,006  

Income tax expense

     17,821       135,500       16,857       186,200  
    


 


 


 


Net income (loss)

   $ 46,565     $ (4,313 )   $ 49,821     $ (104,194 )
    


 


 


 


 

The notes accompanying our financial statements in our Form 10Q are an integral part of these financial statements.


LEVI STRAUSS & CO. AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Dollars in Thousands)

(Unaudited)

 

     Nine Months Ended

 
     August 29, 2004

    August 24, 2003

 

Cash Flows from Operating Activities:

                

Net income (loss)

   $ 49,821     $ (104,194 )

Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:

                

Depreciation and amortization

     45,237       46,610  

Non-cash asset write-offs associated with reorganization initiatives

     34,997       10,968  

Gain on dispositions of property, plant and equipment

     (612 )     (185 )

Unrealized foreign exchange gains

     (13,643 )     (20,145 )

(Increase) decrease in trade receivables

     (11,699 )     68,437  

Decrease (increase) in inventories

     133,621       (198,879 )

Decrease (increase) in other current assets

     13,154       (26,903 )

Decrease in other non-current assets

     11,617       24,590  

(Decrease) increase in accounts payable and accrued liabilities

     (92,342 )     34,628  

Increase in net deferred taxes

     —         (188,232 )

Decrease in restructuring reserves

     (28,877 )     (52,713 )

Addition to deferred tax valuation allowance

     —         282,448  

Increase (decrease) in accrued salaries, wages and employee benefits

     68,131       (97,579 )

Increase (decrease) in accrued taxes

     20,360       (91,352 )

Decrease in long-term employee related benefits

     (95,919 )     (140,258 )

(Decrease) increase in other long-term liabilities

     (32,671 )     34,870  

Other, net

     1,572       (492 )
    


 


Net cash provided by (used for) operating activities

     102,747       (418,381 )
    


 


Cash Flows from Investing Activities:

                

Purchases of property, plant and equipment

     (10,866 )     (50,937 )

Proceeds from sale of property, plant and equipment

     6,672       10,105  

Cash inflow (outflow) from net investment hedges

     1,544       (20,901 )
    


 


Net cash used for investing activities

     (2,650 )     (61,733 )
    


 


Cash Flows from Financing Activities:

                

Proceeds from issuance of long-term debt

     —         1,448,660  

Repayments of long-term debt

     (10,069 )     (955,388 )

Net (decrease) increase in short-term borrowings

     (2,678 )     8,082  

Debt issuance costs

     (2,069 )     (44,878 )

Increase in restricted cash

     (2,053 )     (23,427 )

Other, net

     (996 )     —    
    


 


Net cash (used for) provided by financing activities

     (17,865 )     433,049  
    


 


Effect of exchange rate changes on cash

     22       1,264  
    


 


Net increase (decrease) in cash and cash equivalents

     82,254       (45,801 )

Beginning cash and cash equivalents

     203,940       96,478  
    


 


Ending cash and cash equivalents

   $ 286,194     $ 50,677  
    


 


Supplemental disclosure of cash flow information:

                

Cash paid during the period for:

                

Interest

   $ 198,807     $ 158,837  

Income taxes

     35,564       166,396  

Restructuring initiatives

     102,188       41,147  

 

The notes accompanying our financial statements in our Form 10Q are an integral part of these financial statements.